Genome based metabolic flux analysis of Ethanoligenens harbinense for enhanced hydrogen production
Author
dc.contributor.author
Castro, J. F.
Author
dc.contributor.author
Razmilic, V.
es_CL
Author
dc.contributor.author
Gerdtzen Hakim, Ziomara
es_CL
Admission date
dc.date.accessioned
2014-01-28T14:58:03Z
Available date
dc.date.available
2014-01-28T14:58:03Z
Publication date
dc.date.issued
2013-02-06
Cita de ítem
dc.identifier.citation
INTERNATIONAL JOURNAL OF HYDROGEN ENERGY Volume: 38 Issue: 3 Pages: 1297-1306
en_US
Identifier
dc.identifier.other
DOI: 10.1016/j.ijhydene.2012.11.007
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/126308
General note
dc.description
Artículo de publicación ISI.
en_US
Abstract
dc.description.abstract
Ethanoligenens harbinense is a promising hydrogen producing microorganism due to its
high inherent hydrogen production rate. Even though the effect of media optimization
and inhibitory metabolites has been studied in order to improve the hydrogen
productivity of these cultures, the identification of the underlying causes of the
observed changes in productivity has not been targeted to date. In this work we
present a genome based metabolic flux analysis (MFA) framework, for the comprehensive
study of E. harbinense in culture, and the effect of inhibitory metabolites and
media composition on its metabolic state. A metabolic model was constructed for E.
harbinense based on its annotated genome sequence and proteomic evidence. This
model was employed to perform MFA and obtain the intracellular flux distribution
under different culture conditions. These results allow us to identify key elements in
the metabolism that can be associated to the observed production phenotypes, and
that can be potential targets for metabolic engineering in order to enhanced hydrogen
production in E. harbinense.
en_US
Patrocinador
dc.description.sponsorship
J.F.C. and V.R. were supported by National Doctoral Scholarship,
Conicyt, Chile. We acknowledge funding from Initiation
Grant 11090268 from Fondecyt, Chile.